Ambrx Biopharma Inc (AMAM) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ambrx Biopharma Inc   (NASDAQ: AMAM)


Ambrx Biopharma Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Ambrx Biopharma Inc's ROI in the third quarter of 2023?
Ambrx Biopharma Inc recorded a cumulative net loss of $-134 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -63.25%.

Within the Healthcare sector 680 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 4391, from total ROI ranking in the second quarter of 2023 at 4411.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM 10 % -11.36 % 41.64 % 146.93 % 899.27 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 253 262 195 139 143
Return On Investment (TTM) -63.25 % -68.68 % -79.55 % -82.61 % -70.22 %
AMAM's Overall Ranking # 4391 # 4411 # 0 # 0 #
Seq. Investment Change TTM 14.94 % 6.57 % -1.41 % -8.91 % -7.38 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -134 -127 -138 -145 -135

AMAM Company Profile >> Back to AMAM Roi Comparisons >> See Annual AMAM Return On Investment



Return On Investment AMAM's Ranking
Within: No.
Industry # 106
Sector # 681
Overall # 4391

Return On Investment Statistics
High Average Low
-33.4 %
-65.5 %
-82.61 %
(Dec 31 2021)   (Dec 31 2022)







Financial Statements
Ambrx Biopharma Inc's III. Quarter Investments $ 253 Millions AMAM's Balance sheet
Ambrx Biopharma Inc's III. Quarter Income $ -23 Millions Quarterly AMAM's Income Statement
AMAM's Income by Division See AMAM's Income by Division


AMAM Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Investments in Millions 139 216 0 0 0
Y / Y Investment Growth -35.92 % - - - -
Net Income in Millions -78 -68 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -56.27 % -31.57 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMAM's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMAM's Competitors
Subscribers only: Roi for Ambrx Biopharma Inc's Suppliers
Subscribers only: Return On Investment for AMAM's Customers

Other Ratios
AMAM's Roa AMAM's Inventory Turnover Ratio AMAM's Growth Rates AMAM's Dividend Statistics
AMAM's Profitability Ratios AMAM's Asset Turnover Ratio AMAM's Dividend Growth
AMAM's Roe AMAM's Valuation Ratios AMAM's Financial Strength Ratios AMAM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.